BoZo Research Center
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
23 contract research organizations in our directory list at least one of In Vitro Pharmacology, In Vitro ADME, hERG Assay, Genetic Toxicology, In Vitro Toxicology, Organoid & 3D Models, Binding Kinetics & Affinity or Fc Effector Function Assays, across 11 countries. 16 report GLP capability and 3 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
In vitro work tests compounds in cells, tissues and enzyme systems rather than whole animals. It is fast, inexpensive and well suited to ranking many compounds, so it dominates early discovery and continues through development as part of the regulatory package.
The main areas are in vitro pharmacology (binding, functional and enzyme assays that measure potency and selectivity), in vitro ADME (metabolic stability, permeability, plasma protein binding and CYP inhibition and induction), and in vitro safety, where the hERG assay addresses cardiac risk under ICH S7B and the Ames and in vitro micronucleus assays form the first part of the ICH S2(R1) genotoxicity battery.
Ex vivo assays sit between in vitro and in vivo work: tissues or blood taken from dosed animals, or from human donors, are tested outside the body. Examples include whole blood and PBMC assays, ex vivo receptor occupancy and brain slice electrophysiology. Many sponsors prefer an in vitro lab that also runs in vivo studies, so assays, species and data formats stay consistent when a compound moves into animals.
Showing 23 CROs. Order rotates daily so no lab is permanently listed first.
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
French neuroscience CRO dedicated to in vitro and in vivo models of neurodegenerative and neurological disease, with a US office.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.
Danish non-profit research CRO offering customised cell models, assays and translational research services.
OECD GLP-certified preclinical CRO near Bengaluru providing regulatory toxicology for pharmaceuticals, biologics, devices and chemicals.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.
Hyderabad discovery services company offering biology and DMPK support alongside chemistry.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
Indian GLP test facility offering regulatory toxicology studies for chemicals, agrochemicals and pharmaceuticals.
Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.
Munich-area contract laboratory providing GLP toxicology, genetic toxicology, biocompatibility and microbiology testing for pharmaceutical, chemical and medical device sponsors.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.